Skip to content Skip to footer

2005

Conference Publication

Gender difference in prevalence of non-cystic fibrosis bronchiectasis (NCFB) does not influence clinical phenotype

Kim, S. T., Passmore, L., Dent, A. G., Slaughter, R., Yang, I. A., Fong, K. M., Zimmerman, P. V. and Bell, S. C. (2005). Gender difference in prevalence of non-cystic fibrosis bronchiectasis (NCFB) does not influence clinical phenotype. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, Australia, 18-23 March, 2005. Carlton South, Victoria: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1

Gender difference in prevalence of non-cystic fibrosis bronchiectasis (NCFB) does not influence clinical phenotype

2002

Conference Publication

The positive inotropic effects of norepinephrine are potentiated by chronic beta1-blocker administration but are conserved across Ser49Gly- and Gly389Arg-beta1-adrenergic receptor polymorphisms in human right atrium

Molenaar, P., Russell, F. D., Rabnott, G., Yang, I., Fong, K. M., Savarimuthu, S. M., Li, L. and West, M. J. (2002). The positive inotropic effects of norepinephrine are potentiated by chronic beta1-blocker administration but are conserved across Ser49Gly- and Gly389Arg-beta1-adrenergic receptor polymorphisms in human right atrium. American Heart Association Scientific Sessions 2002, Chicago, 17-20 Nov, 2002. Hagerstown, U.S.A.: Lippincott Williams & Wilkins.

The positive inotropic effects of norepinephrine are potentiated by chronic beta1-blocker administration but are conserved across Ser49Gly- and Gly389Arg-beta1-adrenergic receptor polymorphisms in human right atrium

2000

Conference Publication

Azithromycin (AZM) reduces TNF- release from lipopolysachcharide (LPS) - stimulated mononuclear cells (PBMC) in cystic fibrosis

Bell, S., Wolter, J. M., Seeney, S. L., Gan, R., Yang, I., Bowler, S. D. and Mccormack, J. G. (2000). Azithromycin (AZM) reduces TNF- release from lipopolysachcharide (LPS) - stimulated mononuclear cells (PBMC) in cystic fibrosis. Fourteenth Annual North American Cystic Fibrosis Conference, Baltimore Maryland, USA, 9-12 Novembe, 2000. New York, USA: Wiley Liss, Div John Wiley & Sons.

Azithromycin (AZM) reduces TNF- release from lipopolysachcharide (LPS) - stimulated mononuclear cells (PBMC) in cystic fibrosis

2000

Conference Publication

Azithromycin (AZM) reduced TNF- release from lipopolysachharide (LPS)-stimulated mononuclear cells (PBMC) in cystic fibrosis (CF)

Wolter, J. M., Seeney, S. L., Yang, I. A., Bowler, S. D., Bell, S. and Mccormack, J. G. (2000). Azithromycin (AZM) reduced TNF- release from lipopolysachharide (LPS)-stimulated mononuclear cells (PBMC) in cystic fibrosis (CF). ASID Annual Scientific Meeting, Laura, NSW, 15-19 April, 2001. Balgowlah NSW: ADIS Press Australia.

Azithromycin (AZM) reduced TNF- release from lipopolysachharide (LPS)-stimulated mononuclear cells (PBMC) in cystic fibrosis (CF)

2000

Conference Publication

Tumour necrosis factor (TNF ), myeloperoxides (MPO) and interleukin-1 receptor antagonist polymorphisms in cystic fibrosis.

Gan, R., Bowler, S. D., Seeney, S. L., Wolter, J.M., Masel, P. J., Bunting, J., Tunnicliffe, A. M., Rabnott, G. C., Yang, I. A. and Bell, S. (2000). Tumour necrosis factor (TNF ), myeloperoxides (MPO) and interleukin-1 receptor antagonist polymorphisms in cystic fibrosis.. Fourteenth Annual North American Cystic Fibrosis Conference, Baltimore Maryland, USA, 9-12 Novewmber, 2000. New York USA: Wiley-Liss.

Tumour necrosis factor (TNF ), myeloperoxides (MPO) and interleukin-1 receptor antagonist polymorphisms in cystic fibrosis.

1999

Conference Publication

b2 adrenergic receptor genotypes in severe asthma

Douglas, J. A., Yang, I., Rabnott, G. C., Tunnicliffe, A. M., McCarthy, J. B., Zimmerman, P. V. and Fong, K. M. (1999). b2 adrenergic receptor genotypes in severe asthma. Heart and Lungs, Canberra, 26 Feb - 3 March 1999. Carlton, Vic.: Blackwell Science.

b2 adrenergic receptor genotypes in severe asthma

1999

Conference Publication

b2 adrenoceptor genotypes and life-threatening asthma

Rabnott, G. C., Tunnicliffe, A. M., Yang, I. A., Douglas, J. A., Shaw, J., McCarthy, J. B., Zimmerman, P. V. and Fong, K. M. (1999). b2 adrenoceptor genotypes and life-threatening asthma. Pulmonary-Renal Interface, Hyatt Regency Sanctuary Cove, 26 - 28 Nov, 1999. Qld.: Thoracic Society of Qld..

b2 adrenoceptor genotypes and life-threatening asthma

1999

Conference Publication

GSTT1 and GSTM1 polymorphisms in Australian chronic obstructive pulmonary disease (COPD) patients

Yang, I. A., Gan, R., Tunniclife, A. M., Rabnott, G. C., Zimmerman, P.V. and Fong, K. M. (1999). GSTT1 and GSTM1 polymorphisms in Australian chronic obstructive pulmonary disease (COPD) patients. European Society Annual Congress, Madrid, Spain, 9 - 13 Oct, 1999. Copenhagen, Denmark: European Respiratory Society & Munksgaard Int. Publishers.

GSTT1 and GSTM1 polymorphisms in Australian chronic obstructive pulmonary disease (COPD) patients

1999

Conference Publication

GSTM1 genotypes in Australian patients with NSCLC

Gan, R., Yang, I., Tunnicliffe, A. M., Rabnott, G. C., Bowman, R., Zimmerman, P.V. and Fong, K. M. (1999). GSTM1 genotypes in Australian patients with NSCLC. Heart and Lungs, Canberra, 26 Feb - 3 March 1999. Carlton, Vic.: Blackwell Science.

GSTM1 genotypes in Australian patients with NSCLC

1999

Conference Publication

GSTM1 and GSTP1 polymorphisms in chronic obstructive pulmonary disease (COPD)

Yang, I. A., Gan, R., Tunnicliffe, A. M., Rabnott, G. C., Slaughter, R., Zimmerman, P.V. and Fong, K. M. (1999). GSTM1 and GSTP1 polymorphisms in chronic obstructive pulmonary disease (COPD). Pulmonary-Renal Interface, Hyatt Regency Sanctuary Cove, 26 - 28 Nov, 1999. Qld.: Thoracic Society of Qld..

GSTM1 and GSTP1 polymorphisms in chronic obstructive pulmonary disease (COPD)

1999

Conference Publication

Quantification of pulmonary emphysema using high-resolution computed tomography

Yang, I., Slaughter, R., Roszkowski, A., Fong, K. M. and Zimmerman, P. V. (1999). Quantification of pulmonary emphysema using high-resolution computed tomography. Heart and Lungs., Canberra, 26 Feb - 3 March 1999. Carlton, Vic.: Blackwell Science.

Quantification of pulmonary emphysema using high-resolution computed tomography

1999

Conference Publication

Health informatics in nursing education, research and quality assurance for asthma

Moloney, C., Fong, K. M., Yang, I., Reilly, R. and Zimmerman, P. V. (1999). Health informatics in nursing education, research and quality assurance for asthma. Heart and Lungs, Canberra, 26 Feb - 3 March 1999. Carlton, Vic.: Blackwell Science.

Health informatics in nursing education, research and quality assurance for asthma

1999

Conference Publication

GSTM1 and GSTT1 genotypes in Australians with NSCLC

Gan, R., Yang, I. A., Tunnicliffe, A. M., Rabnott, G. C. and Fong, K. M. (1999). GSTM1 and GSTT1 genotypes in Australians with NSCLC. Pulmonary-Renal Interface, Hyatt Regency Sanctuary Cove, 26 - 28 Nov, 1999. Qld.: Thoracic Society.

GSTM1 and GSTT1 genotypes in Australians with NSCLC